| Bacillus anthracis |
Anthrax lethal factor |
Potency |
2511.9 |
nM |
None |
| Chlorocebus sabaeus |
Vero C1008 |
CC50 |
22400.0 |
nM |
10.6019/CHEMBL4651402 |
| Chlorocebus sabaeus |
Vero C1008 |
pCC50 |
4.65 |
None |
10.6019/CHEMBL4651402 |
| Felis catus |
Felis catus |
Activity A |
0.03 |
uM kg-1 |
10.1021/jm00180a014 |
| Felis catus |
Felis catus |
Activity B |
1.0 |
uM kg-1 |
10.1021/jm00180a014 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
3.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
418.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
Activity |
nan |
None |
10.1073/pnas.0609752104 |
| Homo sapiens |
Bile salt export pump |
IC50 |
111600.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
1584.89 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
2511.89 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
25.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
66.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
1400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
78.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
8.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
13.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
19516.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
8052.4 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
2500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
16.83 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
43.71 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
MES-SA |
Activity |
0.8 |
None |
10.1021/jm0491851 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
2419.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
151.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
203.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
161.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Prion protein |
EC50 |
5000.0 |
nM |
10.1021/jm034093h |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
248.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
144.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
13678.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Whole blood |
Retention_time |
5.67 |
min |
10.1007/s00044-012-9977-1 |
| Mus musculus |
Mus musculus |
ED50 |
6.42 |
uM |
10.1021/jm960814j |
| Mus musculus |
Mus musculus |
ED50 |
nan |
None |
10.1021/jm960814j |
| Mus musculus |
Mus musculus |
Locomotor activity |
11.0 |
uM kg-1 |
10.1021/jm00180a014 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
8087.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
9074.3 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.08942 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
100000.0 |
nM |
10.6019/CHEMBL4651402 |
| Trypanosoma cruzi |
Trypanothione reductase |
IC50 |
502000.0 |
nM |
10.1021/jm960814j |
| None |
ADMET |
LC50 |
10000.0 |
nM |
10.1016/j.bmc.2013.09.022 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
Kd |
100.0 |
nM |
10.1021/jm030650o |
| None |
Unchecked |
EC50 |
6930.0 |
nM |
10.1016/j.bmc.2013.09.022 |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Ratio |
1.44 |
None |
10.1016/j.bmc.2013.09.022 |
| None |
Unchecked |
Ratio |
393.0 |
None |
10.1021/jm00180a014 |